个性化听觉节奏线索以优化老年人和患有帕金森病的人的步态
Elinor C Harrison1, Lauren E Tueth, Allison M Haussler
1Program in Physical Therapy, Washington University in St. Louis School of Medicine, St. Louis, Missouri (E.C.H., L.E.T., A.M.H., K.S.R., and G.M.E), Department of Neurology, Washington University in St. Louis School of Medicine, St. Louis, Missouri (K.S.R. and G.M.E), Department of Neuroscience, Washington University in St. Louis School of Medicine, St. Louis, Missouri (G.M.E), and Performing Arts Department, Washington University in St. Louis, St. Louis, Missouri (E.C.H.).
Journal of neurologic physical therapy : JNPT
|February 6, 2025
概括
个性化的内部和外部线索改善了帕金森病 (PwPD) 患者的行走. 定制提示歌曲和率优化了步伐变化和步伐长度,以获得更好的流动性.
科学领域:
- 神经科学是一个神经科学.
- 运动科学 运动科学
- 康复医学 康复医学 康复医学
背景情况:
- 步行功能障碍是帕金森病 (PwPD) 患者的常见和衰弱症状.
- 内部线索 (精神歌唱) 和外部线索 (音乐) 可能会改善PwPD的行走.
- 个性化提示参数对于最大化治疗效益至关重要.
研究的目的:
- 调查个性化的内部和外部听觉线索在改善PwPD的步行特征方面的有效性.
- 为了确定最佳的暗示率和歌曲选择,以提高步态性能和可变性.
主要方法:
- 一项涉及56名参与者 (28对照组,28PwPD) 进行行走试验的横截面研究.
- 在不同速度 (90-120%的首选节奏) 中,与基于音乐的和在脑海中唱歌的线索进行无线步行的比较.
- 步行参数 (速度,节奏,步长,变化) 用可穿戴传感器测量并通过重复测量ANOVA进行分析.
主要成果:
- 无论是内部还是外部的线索都显著改善了步行速度,节奏和步伐长度,而不是无线路行走.
- 内部线索表明,对步态变化有更大的益处.
- 最高的暗示率 (120%) 通常产生了最长的步伐和最快的速度,而110%是最佳的步态变化.
结论:
- 个性化的听觉线索,考虑歌曲选择和线索速率,可以定制为优化个体的步态.
- 这种方法有望改善步行表现并减少老年人和PwPD的变化.
- 个性化提示策略是帕金森病康复的宝贵工具.
相关概念视频
01:24Parkinson's Disease: Treatment
192
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
192
01:15Parkinson's Disease: Overview
447
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
447